← FDA Drug Approvals (Drugs@FDA)
JOURNAVX
NDA · New Drug Application · Sponsor: VERTEX PHARMS INC · Approved 2025-01-30
Drug application
- FDA Application #
NDA219209- Application type
- New Drug Application
- Brand name
- JOURNAVX
- Generic name
- SUZETRIGINE
- Active ingredients
- SUZETRIGINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- VERTEX PHARMS INC
- Manufacturer
- Vertex Pharmaceuticals Incorporated
- First approval
- 2025-01-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown